A Positron Emission Tomography Occupancy Study Using Ligand [11C]AS2471907 and Following Oral Dosing of ASP3662

NCT02194491 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

18

Enrollment

INDUSTRY

Sponsor class

Conditions

Pharmacokinetics of ASP3662
Displacement of Radiotracer
Healthy Volunteers

Interventions

OTHER: [11C]AS2471907
RADIATION: Positron Emission Tomography (PET)
DRUG: ASP3662

Sponsor

Astellas Pharma Global Development, Inc.

Collaborators

[object Object]